» Articles » PMID: 37065462

Fountain of Youth-Targeting Autophagy in Aging

Overview
Specialty Geriatrics
Date 2023 Apr 17
PMID 37065462
Authors
Affiliations
Soon will be listed here.
Abstract

As our society ages inexorably, geroscience and research focusing on healthy aging is becoming increasingly urgent. Macroautophagy (referred to as autophagy), a highly conserved process of cellular clearance and rejuvenation has attracted much attention due to its universal role in organismal life and death. Growing evidence points to autophagy process as being one of the key players in the determination of lifespan and health. Autophagy inducing interventions show significant improvement in organismal lifespan demonstrated in several experimental models. In line with this, preclinical models of age-related neurodegenerative diseases demonstrate pathology modulating effect of autophagy induction, implicating its potential to treat such disorders. In humans this specific process seems to be more complex. Recent clinical trials of drugs targeting autophagy point out some beneficial effects for clinical use, although with limited effectiveness, while others fail to show any significant improvement. We propose that using more human-relevant preclinical models for testing drug efficacy would significantly improve clinical trial outcomes. Lastly, the review discusses the available cellular reprogramming techniques used to model neuronal autophagy and neurodegeneration while exploring the existing evidence of autophagy's role in aging and pathogenesis in human-derived models such as embryonic stem cells (ESCs), induced pluripotent stem cell derived neurons (iPSC-neurons) or induced neurons (iNs).

Citing Articles

Rejuvenating aged stem cells: therapeutic strategies to extend health and lifespan.

Matteini F, Montserrat-Vazquez S, Florian M FEBS Lett. 2024; 598(22):2776-2787.

PMID: 38604982 PMC: 11586596. DOI: 10.1002/1873-3468.14865.

References
1.
Chen J, Cunha R . The belated US FDA approval of the adenosine A receptor antagonist istradefylline for treatment of Parkinson's disease. Purinergic Signal. 2020; 16(2):167-174. PMC: 7367999. DOI: 10.1007/s11302-020-09694-2. View

2.
Sapp E, Schwarz C, Chase K, Bhide P, Young A, Penney J . Huntingtin localization in brains of normal and Huntington's disease patients. Ann Neurol. 1997; 42(4):604-12. DOI: 10.1002/ana.410420411. View

3.
Atri A, Frolich L, Ballard C, Tariot P, Molinuevo J, Boneva N . Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials. JAMA. 2018; 319(2):130-142. PMC: 5833662. DOI: 10.1001/jama.2017.20373. View

4.
Fu M, Zhang X, Zhang X, Yang L, Luo S, Liu H . Autophagy Plays a Role in the Prolongation of the Life Span of by Astaxanthin. Rejuvenation Res. 2020; 24(3):198-205. DOI: 10.1089/rej.2020.2355. View

5.
Reddy K, Cusack C, Nnah I, Khayati K, Saqcena C, Huynh T . Dysregulation of Nutrient Sensing and CLEARance in Presenilin Deficiency. Cell Rep. 2016; 14(9):2166-2179. PMC: 4793148. DOI: 10.1016/j.celrep.2016.02.006. View